ConductScience.org, home

Paper28126011

Metformin targets multiple signaling pathways in cancer.

Lei Y and 7 others. Chin J Cancer, 2017. Cited by 120 papers, by iCite.

Cite this record

ConductScience Library. Metformin targets multiple signaling pathways in cancer. Papers, record 28126011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28126011

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metformin targets multiple signaling pathways in cancer.
PubMed
Journal
Chin J Cancer
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
120
iCite
Relative citation ratio, by iCite
4.52
iCite
Revised in PubMed
2022-04-08
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lei YYong
2Yi YYanhua
3Liu YYang
4Liu XXia
5Keller ETEvan T
6Qian CNChao-Nan
7Zhang JJian
8Lu YYi

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
MetforminMajor topic
NeoplasmsMajor topic
Animals
Humans
Hypoglycemic Agents
Neoplastic Stem Cells
Signal Transduction

Source PubMed

Download CSV of topics

References128

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112471242Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.Science2002https://conductscience.org/library/papers/12471242PubMed
217062558Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.Cancer Res2006https://conductscience.org/library/papers/17062558PubMed
320363874
AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.
Mol Endocrinol2010https://conductscience.org/library/papers/20363874PubMed
414601044The IGF-1 receptor in cancer biology.Int J Cancer2003https://conductscience.org/library/papers/14601044PubMed
519221486Mitotic kinase dynamics of the active form of AMPK (phospho-AMPKalphaThr172) in human cancer cells.Cell Cycle2009https://conductscience.org/library/papers/19221486PubMed
617085648Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium.Clin Cancer Res2006https://conductscience.org/library/papers/17085648PubMed
723942093Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.Clin Cancer Res2013https://conductscience.org/library/papers/23942093PubMed
819440038Metformin induces unique biological and molecular responses in triple negative breast cancer cells.Cell Cycle2009https://conductscience.org/library/papers/19440038PubMed
923663483Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.BMC Cancer2013https://conductscience.org/library/papers/23663483PubMed
1017355113The transcription factor nuclear factor-kappa B and cancer.Clin Oncol (R Coll Radiol)2007https://conductscience.org/library/papers/17355113PubMed
1121540236Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1.Cancer Res2011https://conductscience.org/library/papers/21540236PubMed
1217712357AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy.Nat Rev Mol Cell Biol2007https://conductscience.org/library/papers/17712357PubMed
1322643892Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC.Nat Commun2012https://conductscience.org/library/papers/22643892PubMed
1425556614The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges.Chin J Cancer2015https://conductscience.org/library/papers/25556614PubMed
1516286006mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events.Cell2005https://conductscience.org/library/papers/16286006PubMed
1620234352mTOR signaling and drug development in cancer.Nat Rev Clin Oncol2010https://conductscience.org/library/papers/20234352PubMed
1725421433Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro.Oncol Rep2015https://conductscience.org/library/papers/25421433PubMed
1818212742The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.Oncogene2008https://conductscience.org/library/papers/18212742PubMed
1915314020Upstream and downstream of mTOR.Genes Dev2004https://conductscience.org/library/papers/15314020PubMed
2024644001Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal.Clin Cancer Res2014https://conductscience.org/library/papers/24644001PubMed

See all 128 referencesDownload CSV of references

Cited by91

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.

PMIDTitleJournalYearIn PapersSource
42948351Metformin Attenuates Glucose-Driven Hepatocellular Carcinoma Progression by Targeting GPD2-Mediated Metabolic Plasticity.Scientifica (Cairo)2026https://conductscience.org/library/papers/42948351PubMed
42358944Combination of metformin and parthenolide inhibits breast cancer in mice by apoptosis induction and angiogenesis inhibition.Front Immunol2026https://conductscience.org/library/papers/42358944PubMed
42199344Coconut oil/lauric acid-based nanodrug formulation: a multifunctional platform for enhancing cancer therapy and mitigating toxicity.Front Cell Dev Biol2026https://conductscience.org/library/papers/42199344PubMed
41899438From Metabolism to Longevity: Molecular Mechanisms Underlying Metformin's Anticancer and Anti-Aging Effects.Curr Issues Mol Biol2026https://conductscience.org/library/papers/41899438PubMed
41893042Metformin Renders Survival Advantage to Patients with Glioblastoma Multiforme.Neurol Int2026https://conductscience.org/library/papers/41893042PubMed
41326661Deciphering genetic susceptibility to clear cell renal cell carcinoma.Commun Biol2025https://conductscience.org/library/papers/41326661PubMed
40901390Antitumor Effects of Metformin in Squamous Cell Carcinoma under Leptin Treatment Conditions.Prev Nutr Food Sci2025https://conductscience.org/library/papers/40901390PubMed
40737255Effects of long-term metformin intake on postoperative clinicopathological characteristics in patients with invasive lung adenocarcinoma and type 2 diabetes mellitus: A retrospective analysis.PLoS One2025https://conductscience.org/library/papers/40737255PubMed
40387523Therapeutic Potential of Anti-Diabetes Drugs and Anti-Dyslipidemia Drugs to Mitigate Head and Neck Cancer Risk in Metabolic Syndrome.CNS Neurosci Ther2025https://conductscience.org/library/papers/40387523PubMed
40115422Enhanced integrated therapy for breast cancer employing Honokiol-loaded mesoporous polydopamine nanoparticles in conjunction with photothermal effects and low-dose metformin.APL Bioeng2025https://conductscience.org/library/papers/40115422PubMed
40091035Investigation of the synergistic effect of metformin and FX11 on PANC-1 cell lines.Biol Res2025https://conductscience.org/library/papers/40091035PubMed
40048168Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists.JAMA Netw Open2025https://conductscience.org/library/papers/40048168PubMed
39970627Metformin and glioma: Targeting metabolic dysregulation for enhanced therapeutic outcomes.Transl Oncol2025https://conductscience.org/library/papers/39970627PubMed
39959483Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers.Heliyon2025https://conductscience.org/library/papers/39959483PubMed
39872949A comparative study of metformin and nicotinamide riboside in alleviating tissue aging in rats.Life Med2023https://conductscience.org/library/papers/39872949PubMed
39844411Preventive and Therapeutic effects of Metformin in Cancer: A Meta- Analysis of RCT and Cohort Studies.Curr Cancer Drug Targets2026https://conductscience.org/library/papers/39844411PubMed
39634308Highly active selenium nanotherapeutics combined with metformin to achieve synergistic sensitizing effect on NK cells for osteosarcoma therapy.Nanophotonics2022https://conductscience.org/library/papers/39634308PubMed
39561737Combination Therapy with Secretome of Reovirus-Infected Mesenchymal Stem Cells and Metformin Improves Anticancer Effects of Irinotecan on Colorectal Cancer Cells in vitro.Intervirology2025https://conductscience.org/library/papers/39561737PubMed
39337118Metformin Treatment Is Not Associated with Altered PD-L1 Expression in Diabetic Patients with Oral Squamous Cell Carcinoma.J Clin Med2024https://conductscience.org/library/papers/39337118PubMed
39063589Comprehensive Evaluation of a Levonorgestrel Intrauterine Device (LNG-IUD), Metformin, and Liraglutide for Fertility Preservation in Endometrial Cancer: Protocol for a Randomized Clinical Trial.Life (Basel)2024https://conductscience.org/library/papers/39063589PubMed

See all 91 cited byDownload CSV of cited by

Genes34

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
CREB11385PubTator's text mininghttps://conductscience.org/library/genes/1385NCBI Gene
CXCR610663PubTator's text mininghttps://conductscience.org/library/genes/10663NCBI Gene
DDIT31649PubTator's text mininghttps://conductscience.org/library/genes/1649NCBI Gene
DDIT454541PubTator's text mininghttps://conductscience.org/library/genes/54541NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EIF4EBP11978PubTator's text mininghttps://conductscience.org/library/genes/1978NCBI Gene
EIF4G11981PubTator's text mininghttps://conductscience.org/library/genes/1981NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERN12081PubTator's text mininghttps://conductscience.org/library/genes/2081NCBI Gene
HSPA53309PubTator's text mininghttps://conductscience.org/library/genes/3309NCBI Gene
IGF13479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene
IGF1R3480PubTator's text mininghttps://conductscience.org/library/genes/3480NCBI Gene
IGF23481PubTator's text mininghttps://conductscience.org/library/genes/3481NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MAPK115600PubTator's text mininghttps://conductscience.org/library/genes/5600NCBI Gene
MAPK75598PubTator's text mininghttps://conductscience.org/library/genes/5598NCBI Gene
MAPK85599PubTator's text mininghttps://conductscience.org/library/genes/5599NCBI Gene

See all 34 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28126011

GET https://conductscience.org/api/papers/v1/28126011/references?page=2